Clinical trials
Withdrawn Phase 4 Hepatitis C trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 5 |
| Merck Sharp & Dohme LLC | 2 |
| Raymond T. Chung, MD | 2 |
| University of Maryland, Baltimore | 2 |
| Albert Einstein Healthcare Network | 1 |
| Douglas T. Dieterich | 1 |
| Kirby Institute | 1 |
| Stanford University | 1 |
| The University of Texas Health Science Center, Houston | 1 |
| University Hospital, Bonn | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 20 |
| Hepatitis C, Chronic | 3 |
| Renal Insufficiency | 3 |
| Kidney Failure, Chronic | 2 |
| Needlestick Injuries | 2 |
| Hepatitis | 1 |
| Inflammation | 1 |
| Insulin Resistance | 1 |
| Kidney Diseases | 1 |
| Metabolic Diseases | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.